{"DataElement":{"publicId":"2007270","version":"1","preferredName":"Brain Tumor Histologic Classification Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis (brain cancer).","longName":"BRAIN_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188996","version":"1","preferredName":"Brain Tumor Histologic Classification","preferredDefinition":"information related to histologic category or classification of a brain tumor.","longName":"BRAI_TUMO_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206623","version":"1","preferredName":"Brain Neoplasm","preferredDefinition":"That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12439:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FCF8-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5CB1E3F-2BA5-3FA0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018978","version":"1","preferredName":"Brain Tumor Histologic Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis (brain cancer).","longName":"BRAIN_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yolk sac tumor","valueDescription":"Yolk Sac Tumor","ValueMeaning":{"publicId":"2566024","version":"1","preferredName":"Yolk Sac Tumor","longName":"2566024","preferredDefinition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells. It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yolk Sac Tumor","conceptCode":"C3011","definition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46B79-99BC-0D72-E034-0003BA12F5E7","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Embryonal carcinoma","valueDescription":"Embryonal carcinoma","ValueMeaning":{"publicId":"2567194","version":"1","preferredName":"Embryonal carcinoma","longName":"2567194","preferredDefinition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Carcinoma","conceptCode":"C3752","definition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D387-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46B79-99BE-0D72-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Choriocarcinoma","valueDescription":"Choriocarcinoma","ValueMeaning":{"publicId":"2574079","version":"1","preferredName":"Choriocarcinoma","longName":"2574079","preferredDefinition":"An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46B79-99C0-0D72-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Teratoma","valueDescription":"Teratoma","ValueMeaning":{"publicId":"2566025","version":"1","preferredName":"Teratoma","longName":"2566025","preferredDefinition":"A non-seminomatous germ cell tumor characterized by the presence of various tissues which correspond to the different germinal layers (endoderm, mesoderm, and ectoderm). It occurs in the testis, ovary, and extragonadal sites including central nervous system, mediastinum, lung, and stomach. According to the level of differentiation of the tissues which comprise the tumor, teratomas are classified as mature or immature. Mature teratomas are composed of well differentiated, adult-type tissues. Immature teratomas are composed of immature, fetal-type tissues. Testicular teratomas in children follow a benign clinical course. Mature ovarian teratomas without a fetal-type component have an excellent outcome. The prognosis of immature ovarian teratomas is related to the grade and stage of the tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Teratoma","conceptCode":"C3403","definition":"A non-seminomatous germ cell tumor characterized by the presence of various tissues which correspond to the different germinal layers (endoderm, mesoderm, and ectoderm). It occurs in the testis, ovary, and extragonadal sites including central nervous system, mediastinum, lung, and stomach. According to the level of differentiation of the tissues which comprise the tumor, teratomas are classified as benign (grade 0 or 1), immature (grade 2), and malignant (grade 3). Grade 0 teratomas contain only mature elements; grade 1 teratomas have a limited degree of immaturity; grade 2 teratomas have a more extensive degree of immaturity; grade 3 teratomas are composed exclusively of immature tissues. The prognosis depends on patient age, tumor size and grade, and stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added system generated definition for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46B79-99C3-0D72-E034-0003BA12F5E7","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Mixed germ cell tumors","valueDescription":"Mixed germ cell tumor","ValueMeaning":{"publicId":"2566026","version":"1","preferredName":"Mixed germ cell tumor","longName":"2566026","preferredDefinition":"Mixed germ cell tumor","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Germ Cell Tumor","conceptCode":"C4285","definition":"Definition not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEF7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46B79-99C6-0D72-E034-0003BA12F5E7","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE46C9C-0A95-0D6C-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diffuse astrocytoma","valueDescription":"Diffuse astrocytoma","ValueMeaning":{"publicId":"2578704","version":"1","preferredName":"Diffuse astrocytoma","longName":"2578704","preferredDefinition":"A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma","conceptCode":"C7173","definition":"A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DC8F-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Fibrillary astrocytoma","valueDescription":"9420-3 Fibrillary astrocytoma (C71._)","ValueMeaning":{"publicId":"2564972","version":"1","preferredName":"9420-3 Fibrillary astrocytoma (C71._)","longName":"2564972","preferredDefinition":"Fibrillary astrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DC93-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Protoplasmic astrocytoma","valueDescription":"9410-3 Protoplasmic astrocytoma (C71._)","ValueMeaning":{"publicId":"2564968","version":"1","preferredName":"9410-3 Protoplasmic astrocytoma (C71._)","longName":"2564968","preferredDefinition":"Protoplasmic astrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DC97-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gemistocytic astrocytoma","valueDescription":"9411-3 Gemistocytic astrocytoma (C71._)","ValueMeaning":{"publicId":"2564969","version":"1","preferredName":"9411-3 Gemistocytic astrocytoma (C71._)","longName":"2564969","preferredDefinition":"Gemistocytic astrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DC9B-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma","valueDescription":"9401-3 Astrocytoma, anaplastic (C71._)","ValueMeaning":{"publicId":"2564967","version":"1","preferredName":"9401-3 Astrocytoma, anaplastic (C71._)","longName":"2564967","preferredDefinition":"Astrocytoma, anaplastic (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DC9F-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Glioblastoma","valueDescription":"9440-3 Glioblastoma, NOS (C71._)","ValueMeaning":{"publicId":"2564977","version":"1","preferredName":"9440-3 Glioblastoma, NOS (C71._)","longName":"2564977","preferredDefinition":"Glioblastoma, NOS (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CADE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-81F4-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Giant cell glioblastoma","valueDescription":"9441-3 Giant cell glioblastoma (C71._)","ValueMeaning":{"publicId":"2564978","version":"1","preferredName":"9441-3 Giant cell glioblastoma (C71._)","longName":"2564978","preferredDefinition":"Giant cell glioblastoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CADF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-81F8-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gliosarcoma","valueDescription":"9442-3 Gliosarcoma (C71._)","ValueMeaning":{"publicId":"2564980","version":"1","preferredName":"9442-3 Gliosarcoma (C71._)","longName":"2564980","preferredDefinition":"Gliosarcoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-81FC-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pilocytic astrocytoma","valueDescription":"9421-1 Pilocytic astrocytoma (C71._)","ValueMeaning":{"publicId":"2564973","version":"1","preferredName":"9421-1 Pilocytic astrocytoma (C71._)","longName":"2564973","preferredDefinition":"Pilocytic astrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CADA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-8200-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pleomorphic xanthoastrocytoma","valueDescription":"9424-3 Pleomorphic xanthoastrocytoma (C71._)","ValueMeaning":{"publicId":"2564975","version":"1","preferredName":"9424-3 Pleomorphic xanthoastrocytoma (C71._)","longName":"2564975","preferredDefinition":"Pleomorphic xanthoastrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CADC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-8204-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"squamous cell","valueDescription":"squamous cell","ValueMeaning":{"publicId":"2568691","version":"1","preferredName":"squamous cell","longName":"2568691","preferredDefinition":"squamous cell","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D960-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5D7109E-9B68-5385-E034-0003BA12F5E7","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"large cell","valueDescription":"large cell","ValueMeaning":{"publicId":"2568692","version":"1","preferredName":"large cell","longName":"2568692","preferredDefinition":"large cell","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D961-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5D50EA0-2849-3E76-E034-0003BA12F5E7","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"melanoma","valueDescription":"Melanoma","ValueMeaning":{"publicId":"2567413","version":"1","preferredName":"Melanoma","longName":"2567413","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D462-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5D50EA0-284D-3E76-E034-0003BA12F5E7","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"DWARZEL","dateModified":"2006-08-30","deletedIndicator":"No"},{"value":"adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5D50EA0-2850-3E76-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"small cell","valueDescription":"small cell","ValueMeaning":{"publicId":"2568693","version":"1","preferredName":"small cell","longName":"2568693","preferredDefinition":"small cell","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D962-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5D50EA0-2853-3E76-E034-0003BA12F5E7","beginDate":"2004-03-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Germinoma","valueDescription":"9064-3 Germinoma","ValueMeaning":{"publicId":"2564802","version":"1","preferredName":"9064-3 Germinoma","longName":"2564802","preferredDefinition":"Germinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CA2F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F3ECC-843A-2282-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Craniopharyngioma","valueDescription":"9350-1 Craniopharyngioma (C75.2)","ValueMeaning":{"publicId":"2564940","version":"1","preferredName":"9350-1 Craniopharyngioma (C75.2)","longName":"2564940","preferredDefinition":"Craniopharyngioma (C75.2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAB9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5602B59-CCD3-29B4-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Adamantinomatous","valueDescription":"9351-1 Craniopharyngioma, adamantinomatous (C75.2)","ValueMeaning":{"publicId":"2564941","version":"1","preferredName":"9351-1 Craniopharyngioma, adamantinomatous (C75.2)","longName":"2564941","preferredDefinition":"Craniopharyngioma, adamantinomatous (C75.2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CABA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5602B59-CCD7-29B4-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"9352-1 Craniopharyngioma, papillary (C75.2)","ValueMeaning":{"publicId":"2564942","version":"1","preferredName":"9352-1 Craniopharyngioma, papillary (C75.2)","longName":"2564942","preferredDefinition":"Craniopharyngioma, papillary (C75.2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CABB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5602B59-CCDB-29B4-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Granular cell tumor","valueDescription":"9580-0 Granular cell tumor, NOS","ValueMeaning":{"publicId":"2565048","version":"1","preferredName":"9580-0 Granular cell tumor, NOS","longName":"2565048","preferredDefinition":"Granular cell tumor, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB25-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5602B59-CCDF-29B4-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Meningothelial meningioma","valueDescription":"9531-0 Meningothelial meningioma","ValueMeaning":{"publicId":"2565023","version":"1","preferredName":"9531-0 Meningothelial meningioma","longName":"2565023","preferredDefinition":"Meningothelial meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB0C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5602B59-CCE2-29B4-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Fibrous meningioma","valueDescription":"9532-0 Fibrous meningioma","ValueMeaning":{"publicId":"2565024","version":"1","preferredName":"9532-0 Fibrous meningioma","longName":"2565024","preferredDefinition":"Fibrous meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB0D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5616D28-98C3-4F28-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Transitional meningioma","valueDescription":"9537-0 Transitional meningioma","ValueMeaning":{"publicId":"2565028","version":"1","preferredName":"9537-0 Transitional meningioma","longName":"2565028","preferredDefinition":"Transitional meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB11-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5616D28-98C6-4F28-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Psammomatous meningioma","valueDescription":"9533-0 Psammomatous meningioma","ValueMeaning":{"publicId":"2565025","version":"1","preferredName":"9533-0 Psammomatous meningioma","longName":"2565025","preferredDefinition":"Psammomatous meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5616D28-98C9-4F28-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Angiomatous meningioma","valueDescription":"9534-0 Angiomatous meningioma","ValueMeaning":{"publicId":"2565026","version":"1","preferredName":"9534-0 Angiomatous meningioma","longName":"2565026","preferredDefinition":"Angiomatous meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5616D28-98CC-4F28-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Microcystic meningioma","valueDescription":"Microcystic meningioma","ValueMeaning":{"publicId":"2568660","version":"1","preferredName":"Microcystic meningioma","longName":"2568660","preferredDefinition":"Microcystic meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D941-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5616D28-98D0-4F28-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Secretory meningioma","valueDescription":"Secretory meningioma","ValueMeaning":{"publicId":"2568663","version":"1","preferredName":"Secretory meningioma","longName":"2568663","preferredDefinition":"Secretory meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D944-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560AB53-FA61-5282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Lymphoplasmacyte-rich meningioma","valueDescription":"Lymphoplasmacyte-rich meningioma","ValueMeaning":{"publicId":"2568662","version":"1","preferredName":"Lymphoplasmacyte-rich meningioma","longName":"2568662","preferredDefinition":"Lymphoplasmacyte-rich meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D943-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560AB53-FA65-5282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Metaplastic meningioma","valueDescription":"Metaplastic meningioma","ValueMeaning":{"publicId":"2568661","version":"1","preferredName":"Metaplastic meningioma","longName":"2568661","preferredDefinition":"Metaplastic meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D942-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560AB53-FA69-5282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Atypical meningioma","valueDescription":"9539-1 Atypical meningioma","ValueMeaning":{"publicId":"2565031","version":"1","preferredName":"9539-1 Atypical meningioma","longName":"2565031","preferredDefinition":"Atypical meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560AB53-FA6C-5282-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Clear cell meningioma","valueDescription":"9538-1 Clear cell meningioma","ValueMeaning":{"publicId":"2565029","version":"1","preferredName":"9538-1 Clear cell meningioma","longName":"2565029","preferredDefinition":"Clear cell meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB12-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560AB53-FA6F-5282-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chordoid meningioma","valueDescription":"Chordoid meningioma","ValueMeaning":{"publicId":"2568664","version":"1","preferredName":"Chordoid meningioma","longName":"2568664","preferredDefinition":"Chordoid meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D945-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560BD1E-91FA-543E-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Rhabdoid meningioma","valueDescription":"Rhabdoid meningioma","ValueMeaning":{"publicId":"2568665","version":"1","preferredName":"Rhabdoid meningioma","longName":"2568665","preferredDefinition":"Rhabdoid meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D946-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560BD1E-91FE-543E-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Papillary meningioma","valueDescription":"9538-3  Papillary meningioma","ValueMeaning":{"publicId":"2565030","version":"1","preferredName":"9538-3  Papillary meningioma","longName":"2565030","preferredDefinition":"Papillary meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB13-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560BD1E-9201-543E-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic meningioma","valueDescription":"Anaplastic meningioma","ValueMeaning":{"publicId":"2568666","version":"1","preferredName":"Anaplastic meningioma","longName":"2568666","preferredDefinition":"Anaplastic meningioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D947-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D560BD1E-9205-543E-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Subependymal giant cell astrocytoma","valueDescription":"9384-1 Subependymal giant cell astrocytoma (C71._)","ValueMeaning":{"publicId":"2564958","version":"1","preferredName":"9384-1 Subependymal giant cell astrocytoma (C71._)","longName":"2564958","preferredDefinition":"Subependymal giant cell astrocytoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CACB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54C3-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Oligodendroglioma","valueDescription":"9450-3 Oligodendroglioma, NOS (C71._)","ValueMeaning":{"publicId":"2564982","version":"1","preferredName":"9450-3 Oligodendroglioma, NOS (C71._)","longName":"2564982","preferredDefinition":"Not characterized in any other way.: A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor of adults, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance).  It generally recurs locally, with median post-operative survival times ranging from 3 to 5 years for patients with all histological grades. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Oligodendroglioma","conceptCode":"C3288","definition":"A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54C7-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Oligoastrocytoma","valueDescription":"Oligoastrocytoma","ValueMeaning":{"publicId":"2568645","version":"1","preferredName":"Oligoastrocytoma","longName":"2568645","preferredDefinition":"A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma","conceptCode":"C4050","definition":"A WHO grade 2 tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54CB-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic oligoastrocytoma","valueDescription":"Anaplastic oligoastrocytoma","ValueMeaning":{"publicId":"2568646","version":"1","preferredName":"Anaplastic oligoastrocytoma","longName":"2568646","preferredDefinition":"Anaplastic Oligoastrocytoma is an Oligoastrocytoma with histological features of malignancy, such as increased cellularity, nuclear atypia, pleomorphism, and increased mitotic activity. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma","conceptCode":"C6959","definition":"An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D933-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54CF-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoma","valueDescription":"9391-3 Ependymoma, NOS (C71._)","ValueMeaning":{"publicId":"2564962","version":"1","preferredName":"9391-3 Ependymoma, NOS (C71._)","longName":"2564962","preferredDefinition":"Ependymoma, NOS (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CACF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54D3-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma","valueDescription":"9451-3 Oligodendroglioma, anaplastic (C71._)","ValueMeaning":{"publicId":"2564983","version":"1","preferredName":"9451-3 Oligodendroglioma, anaplastic (C71._)","longName":"2564983","preferredDefinition":"Oligodendroglioma, anaplastic (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCA3-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic ependymoma","valueDescription":"9392-3 Ependymoma, anaplastic (C71._)","ValueMeaning":{"publicId":"2564963","version":"1","preferredName":"9392-3 Ependymoma, anaplastic (C71._)","longName":"2564963","preferredDefinition":"Ependymoma, anaplastic (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCA7-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Myxopapillary ependymoma","valueDescription":"9394-1 Myxopapillary ependymoma (C72.0)","ValueMeaning":{"publicId":"2564965","version":"1","preferredName":"9394-1 Myxopapillary ependymoma (C72.0)","longName":"2564965","preferredDefinition":"Myxopapillary ependymoma (C72.0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCAB-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Subependymoma","valueDescription":"9383-1 Subependymoma (C71._)","ValueMeaning":{"publicId":"2564957","version":"1","preferredName":"9383-1 Subependymoma (C71._)","longName":"2564957","preferredDefinition":"Subependymoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CACA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCAF-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Choroid plexus papilloma","valueDescription":"9390-0 Choroid plexus papilloma, NOS (C71.5)","ValueMeaning":{"publicId":"2564959","version":"1","preferredName":"9390-0 Choroid plexus papilloma, NOS (C71.5)","longName":"2564959","preferredDefinition":"Choroid plexus papilloma, NOS (C71.5)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CACC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCB3-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Choroid plexus carcinoma","valueDescription":"9390-3 Choroid plexus carcinoma (C71.5)","ValueMeaning":{"publicId":"2564961","version":"1","preferredName":"9390-3 Choroid plexus carcinoma (C71.5)","longName":"2564961","preferredDefinition":"Choroid plexus carcinoma (C71.5)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CACE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCB7-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Astroblastoma","valueDescription":"9430-3 Astroblastoma (C71._)","ValueMeaning":{"publicId":"2564976","version":"1","preferredName":"9430-3 Astroblastoma (C71._)","longName":"2564976","preferredDefinition":"Astroblastoma (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CADD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCBB-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gliomatosis cerebri","valueDescription":"9381-3 Gliomatosis cerebri (C71._)","ValueMeaning":{"publicId":"2564955","version":"1","preferredName":"9381-3 Gliomatosis cerebri (C71._)","longName":"2564955","preferredDefinition":"Gliomatosis cerebri (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAC8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCBF-1ABF-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Gangliocytoma","valueDescription":"9492-0 Gangliocytoma","ValueMeaning":{"publicId":"2564995","version":"1","preferredName":"9492-0 Gangliocytoma","longName":"2564995","preferredDefinition":"Gangliocytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAF0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EDC4E-DCC2-1ABF-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chordoid glioma of the third ventricle","valueDescription":"Chordoid glioma of the third ventricle","ValueMeaning":{"publicId":"2568647","version":"1","preferredName":"Chordoid glioma of the third ventricle","longName":"2568647","preferredDefinition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chordoid Glioma of the Third Ventricle","conceptCode":"C6961","definition":"Chordoid Glioma of the 3rd Ventricle is a rare, slow growing, glial tumor located in the third ventricle of adults. It is characterized histologically by clusters and cords of epithelioid, GFAP expressing tumor cells within a stroma with varying amounts of mucin, which typically contains a lymphoplasmacytic infiltrate. (Adapted from WHO.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D934-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550412E-9151-1DB9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Dysplastic gangliocytoma of cerebellum","valueDescription":"9493-0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)","ValueMeaning":{"publicId":"2564996","version":"1","preferredName":"9493-0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)","longName":"2564996","preferredDefinition":"Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAF1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550412E-9155-1DB9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Desmoplastic infantile astrocytoma/ganglioma","valueDescription":"Desmoplastic infantile astrocytoma/ganglioma","ValueMeaning":{"publicId":"2568649","version":"1","preferredName":"Desmoplastic infantile astrocytoma/ganglioma","longName":"2568649","preferredDefinition":"Desmoplastic infantile astrocytoma/ganglioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D936-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550412E-9159-1DB9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Low grade astrocytoma NOS","valueDescription":"Low grade astrocytoma, NOS","ValueMeaning":{"publicId":"2568650","version":"1","preferredName":"Low grade astrocytoma, NOS","longName":"2568650","preferredDefinition":"Not characterized in any other way.: Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.: A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Astrocytoma","conceptCode":"C60781","definition":"A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D937-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concepts to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550412E-915D-1DB9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Dysembryoplastic neuroepithelial tumor","valueDescription":"9413-0 Dysembryoplastic neuroepithelial tumor","ValueMeaning":{"publicId":"2564971","version":"1","preferredName":"9413-0 Dysembryoplastic neuroepithelial tumor","longName":"2564971","preferredDefinition":"Dysembryoplastic neuroepithelial tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAD8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550412E-9160-1DB9-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ganglioglioma","valueDescription":"9505-1 Ganglioglioma, NOS","ValueMeaning":{"publicId":"2565004","version":"1","preferredName":"9505-1 Ganglioglioma, NOS","longName":"2565004","preferredDefinition":"Ganglioglioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAF9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-8208-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Anaplastic ganglioglioma","valueDescription":"9505-3 Ganglioglioma, anaplastic","ValueMeaning":{"publicId":"2565005","version":"1","preferredName":"9505-3 Ganglioglioma, anaplastic","longName":"2565005","preferredDefinition":"Ganglioglioma, anaplastic","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAFA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-820C-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Central neurocytoma","valueDescription":"9506-1 Central neurocytoma","ValueMeaning":{"publicId":"2565006","version":"1","preferredName":"9506-1 Central neurocytoma","longName":"2565006","preferredDefinition":"Central neurocytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAFB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-820F-18B9-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Paraganglioma of the filum terminale","valueDescription":"Paraganglioma of the filum terminale","ValueMeaning":{"publicId":"2568651","version":"1","preferredName":"Paraganglioma of the filum terminale","longName":"2568651","preferredDefinition":"An extra-adrenal spinal paraganglioma arising from the cauda equina.  It should not be confused with glomus coccygeum, a structure unrelated to paraganglia.  Clinically, it may be asymptomatic or present with cauda equina syndrome, lower back pain, or leg pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cauda Equina Neuroendocrine Tumor","conceptCode":"C5324","definition":"A slow-growing, well-differentiated neuroendocrine neoplasm arising from the cauda equina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D938-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-8213-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Cerebellar liponeurocytoma","valueDescription":"Cerebellar liponeurocytoma","ValueMeaning":{"publicId":"2578720","version":"1","preferredName":"Cerebellar liponeurocytoma","longName":"2578720","preferredDefinition":"Cerebellar Liponeurocytoma (WHO grade I or II) is a rare cerebellar neoplasm which shows advanced neuronal/neurocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and has a favorable clinical prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebellar Liponeurocytoma","conceptCode":"C6905","definition":"A rare, WHO grade II cerebellar neoplasm which shows consistent neuronal, variable astrocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and usually has a favorable prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-008D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D54EE281-8217-18B9-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Olfactory neuroblastoma","valueDescription":"9522-3 Olfactory neuroblastoma (C30.0)","ValueMeaning":{"publicId":"2565017","version":"1","preferredName":"9522-3 Olfactory neuroblastoma (C30.0)","longName":"2565017","preferredDefinition":"Olfactory neuroblastoma (C30.0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB06-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54D7-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Olfactory neuroepithelioma","valueDescription":"9523-3  Olfactory neuroepithelioma (C30.0)","ValueMeaning":{"publicId":"2565018","version":"1","preferredName":"9523-3  Olfactory neuroepithelioma (C30.0)","longName":"2565018","preferredDefinition":"Olfactory neuroepithelioma (C30.0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CB07-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54DB-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neuroblastomas of the adrenal gland and sympathetic nervous system","valueDescription":"Neuroblastomas of the adrenal gland and sympathetic nervous system","ValueMeaning":{"publicId":"2568652","version":"1","preferredName":"Neuroblastomas of the adrenal gland and sympathetic nervous system","longName":"2568652","preferredDefinition":"Neuroblastomas of the adrenal gland and sympathetic nervous system","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D939-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54DF-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineocytoma","valueDescription":"9361-1 Pineocytoma (C75.3)","ValueMeaning":{"publicId":"2564944","version":"1","preferredName":"9361-1 Pineocytoma (C75.3)","longName":"2564944","preferredDefinition":"Pineocytoma (C75.3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CABD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54E3-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineoblastoma","valueDescription":"9362-3 Pineoblastoma (C75.3)","ValueMeaning":{"publicId":"2564945","version":"1","preferredName":"9362-3 Pineoblastoma (C75.3)","longName":"2564945","preferredDefinition":"Pineoblastoma (C75.3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CABE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D550101C-54E7-18AD-E034-0003BA12F5E7","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pineal parenchymal tumor of indeterminate differentiation","valueDescription":"Pineal parenchymal tumor of indeterminate differentiation","ValueMeaning":{"publicId":"2568653","version":"1","preferredName":"Pineal parenchymal tumor of indeterminate differentiation","longName":"2568653","preferredDefinition":"Pineal parenchymal tumor of indeterminate differentiation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F6B17-7020-1D59-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloepithelioma","valueDescription":"9501-3 Medulloepithelioma, NOS","ValueMeaning":{"publicId":"2564999","version":"1","preferredName":"9501-3 Medulloepithelioma, NOS","longName":"2564999","preferredDefinition":"Medulloepithelioma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F6B17-7024-1D59-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ependymoblastoma","valueDescription":"Ependymoblastoma","ValueMeaning":{"publicId":"2568654","version":"1","preferredName":"Ependymoblastoma","longName":"2568654","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered","conceptCode":"C4915","definition":"An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F6B17-7028-1D59-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medulloblastoma","valueDescription":"9470-3 Medulloblastoma, NOS (C71.6)","ValueMeaning":{"publicId":"2564985","version":"1","preferredName":"9470-3 Medulloblastoma, NOS (C71.6)","longName":"2564985","preferredDefinition":"Medulloblastoma, NOS (C71.6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F6B17-702C-1D59-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Desmoplastic medulloblastoma","valueDescription":"Desmoplastic medulloblastoma","ValueMeaning":{"publicId":"2578724","version":"1","preferredName":"Desmoplastic medulloblastoma","longName":"2578724","preferredDefinition":"Desmoplastic Medulloblastoma is a variant of Medulloblastoma. Some histologic features of this lesion include nodular, reticulin-free zones ('pale islands') surrounded by densely packed, highly proliferative cells that produce a dense intercellular reticulin fiber network. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic/Nodular Medulloblastoma","conceptCode":"C4956","definition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0091-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F6B17-7030-1D59-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Large cell medulloblastoma","valueDescription":"9474-3 Large cell medulloblastoma (C71.6)","ValueMeaning":{"publicId":"2564989","version":"1","preferredName":"9474-3 Large cell medulloblastoma (C71.6)","longName":"2564989","preferredDefinition":"Large cell medulloblastoma (C71.6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAEA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55E9708-EC51-2271-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Medullomyoblastoma","valueDescription":"9472-3 Medullomyoblastoma (C71.6)","ValueMeaning":{"publicId":"2564987","version":"1","preferredName":"9472-3 Medullomyoblastoma (C71.6)","longName":"2564987","preferredDefinition":"Medullomyoblastoma (C71.6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAE8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55E9708-EC55-2271-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Supratentorial primitive neuroectodermal tumor","valueDescription":"Supratentorial primitive neuroectodermal tumor (PNET)","ValueMeaning":{"publicId":"2568656","version":"1","preferredName":"Supratentorial primitive neuroectodermal tumor (PNET)","longName":"2568656","preferredDefinition":"Supratentorial primitive neuroectodermal tumor (PNET)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55E9708-EC5D-2271-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Neuroblastoma","valueDescription":"9500-3 Neuroblastoma, NOS","ValueMeaning":{"publicId":"2564997","version":"1","preferredName":"9500-3 Neuroblastoma, NOS","longName":"2564997","preferredDefinition":"Neuroblastoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAF2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55E9708-EC61-2271-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ganglioneuroblastoma","valueDescription":"9490-3 Ganglioneuroblastoma","ValueMeaning":{"publicId":"2564993","version":"1","preferredName":"9490-3 Ganglioneuroblastoma","longName":"2564993","preferredDefinition":"Ganglioneuroblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAEE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F3ECC-842B-2282-E034-0003BA12F5E7","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Atypical teratoid/rhabdoid tumor","valueDescription":"9508-3 Atypical teratoid-rhabdoid tumor (C71._)","ValueMeaning":{"publicId":"2565008","version":"1","preferredName":"9508-3 Atypical teratoid-rhabdoid tumor (C71._)","longName":"2565008","preferredDefinition":"Atypical teratoid/rhabdoid tumor (C71._)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CAFD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"JASUR","dateCreated":"2003-01-27","modifiedBy":"ONEDATA","dateModified":"2003-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F3ECC-842F-2282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Schwannoma","valueDescription":"Schwannoma (Neurilemmoma, Neurinoma)","ValueMeaning":{"publicId":"2568657","version":"1","preferredName":"Schwannoma (Neurilemmoma, Neurinoma)","longName":"2568657","preferredDefinition":"Schwannoma (Neurilemmoma, Neurinoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F3ECC-8433-2282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"High grade astrocytoma NOS","valueDescription":"High grade astrocytoma, NOS","ValueMeaning":{"publicId":"2568658","version":"1","preferredName":"High grade astrocytoma, NOS","longName":"2568658","preferredDefinition":"High grade astrocytoma, NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55F3ECC-8437-2282-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Melanotic medulloblastoma","valueDescription":"Melanotic medulloblastoma","ValueMeaning":{"publicId":"2568655","version":"1","preferredName":"Melanotic medulloblastoma","longName":"2568655","preferredDefinition":"Melanotic Medulloblastoma (WHO grade IV) is a rare tumor of childhood with a predominant element of small round cells closely resembling classic medulloblastoma and a minor component of melanin-forming neuroepithelial cells. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanocytic Medulloblastoma","conceptCode":"C9497","definition":"A rare malignant embryonal neoplasm characterized by the presence of small cells which resemble the cells of classic medulloblastoma and a minor population of melanin-forming neuroepithelial cells.  It usually has an unfavorable clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D55E9708-EC59-2271-E034-0003BA12F5E7","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Astrocytoma","valueDescription":"Astrocytoma","ValueMeaning":{"publicId":"2574991","version":"1","preferredName":"Astrocytoma","longName":"2574991","preferredDefinition":"Astrocytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F1FC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"REEVESD","dateModified":"2005-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D09972A-5DD2-7C2C-E040-BB89AD43336B","beginDate":"2009-06-23","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-06-23","modifiedBy":"ONEDATA","dateModified":"2009-06-23","deletedIndicator":"No"},{"value":"Endodermal sinus tumor (yolk sac)","valueDescription":"Endodermal sinus tumor (yolk sac)","ValueMeaning":{"publicId":"3412718","version":"1","preferredName":"Endodermal sinus tumor (yolk sac)","longName":"3412718","preferredDefinition":"Endodermal sinus tumor (yolk sac)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB1063B9-E7EF-5F5A-E040-BB89AD4367BE","latestVersionIndicator":"Yes","beginDate":"2012-03-12","endDate":null,"createdBy":"WONGW","dateCreated":"2012-03-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB1063B9-E808-5F5A-E040-BB89AD4367BE","beginDate":"2012-03-12","endDate":null,"createdBy":"WONGW","dateCreated":"2012-03-12","modifiedBy":"ONEDATA","dateModified":"2012-03-12","deletedIndicator":"No"},{"value":"Germinoma","valueDescription":"Germinoma","ValueMeaning":{"publicId":"2578733","version":"1","preferredName":"Germinoma","longName":"2578733","preferredDefinition":"The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB1063B9-E854-5F5A-E040-BB89AD4367BE","beginDate":"2012-03-12","endDate":null,"createdBy":"WONGW","dateCreated":"2012-03-12","modifiedBy":"ONEDATA","dateModified":"2012-03-12","deletedIndicator":"No"},{"value":"Malignant/immature teratoma","valueDescription":"Malignant/immature teratoma","ValueMeaning":{"publicId":"3379924","version":"1","preferredName":"Malignant/immature teratoma","longName":"3379924","preferredDefinition":"Malignant/immature teratoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B930EB50-43B9-F8B7-E040-BB89AD433DC9","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B930EB50-43D2-F8B7-E040-BB89AD433DC9","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Mixed GCT with malignant GCT elements","valueDescription":"Mixed GCT with malignant GCT elements","ValueMeaning":{"publicId":"3379925","version":"1","preferredName":"Mixed GCT with malignant GCT elements","longName":"3379925","preferredDefinition":"Mixed GCT with malignant GCT elements","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B930EB50-4408-F8B7-E040-BB89AD433DC9","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B930EB50-4421-F8B7-E040-BB89AD433DC9","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Germinoma mixed with mature teratoma","valueDescription":"Germinoma mixed with mature teratoma","ValueMeaning":{"publicId":"3379926","version":"1","preferredName":"Germinoma mixed with mature teratoma","longName":"3379926","preferredDefinition":"Germinoma mixed with mature teratoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B930FCA0-125F-889E-E040-BB89AD430407","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B930FCA0-1278-889E-E040-BB89AD430407","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE4644D-2689-0D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"PWEST","dateModified":"2014-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"},{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"2812013","version":"1","longName":"Primary Brain New","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3140556","version":"1","longName":"Denise Test CS","context":"TEST","ClassificationSchemeItems":[{"publicId":"3140557","version":"1","longName":"Denise Sentinel CSI","context":"TEST"}]}],"AlternateNames":[{"name":"BRAIN_TUMOR_HIST_CAT","type":"USED_BY","context":"NCIP"},{"name":"BRAIN_TUMOR_HIST_CAT","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"CTEP"},{"name":"COG Text 1","type":"Alternate Question Text","description":"What is the histologic diagnosis of malignancy for which this patient was enrolled on this study?","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BEE45D74-BA55-0D82-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"DWARZEL","dateModified":"2022-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}